This document lists 20 research publications from 2008 to 1999 by authors Sidi A, Muehlschlegel JD, Kirby DS, and Lobato EB studying treatments for pulmonary hypertension, myocardial ischemia, and cardiac dysfunction in pig models. The publications examine drugs like sildenafil, milrinone, dobutamine, hypertonic saline, and amyl nitrite administered before, during, or after events like coronary occlusion or ischemia to evaluate effects on pulmonary pressure, cardiac function, and metabolic impairment. Measurement methods compared in some studies include thermodilution, noninvasive partial CO2 rebreathing, and direct aortic flow.
Arginine Cardio - Lowering your blood pressureArginine Cardio
Arginine Cardio can do wonders in treating various heart related problems, including High BP, lower energy level, anti-aging, cleaning of the arterial system, etc. Read more @ http://bit.ly/1rnsRYQ
Learn about how to lower blood pressure and why Arginine Cardio is the world’s greatest supplement for improving the cardiovascular health. Visit today for buying the product for very reasonable price with no shipping cost.
Arginine Cardio - Lowering your blood pressureArginine Cardio
Arginine Cardio can do wonders in treating various heart related problems, including High BP, lower energy level, anti-aging, cleaning of the arterial system, etc. Read more @ http://bit.ly/1rnsRYQ
Learn about how to lower blood pressure and why Arginine Cardio is the world’s greatest supplement for improving the cardiovascular health. Visit today for buying the product for very reasonable price with no shipping cost.
Mesurement of cretinine kinase from blood of a cardiac patientAtai Rabby
The development of sensitive spectrophotometer able to measure a wide range of wavelengths has allowed natural substrates and measurements in the ultraviolet region of the spectrum to be used in clinical tests. Assays using natural substrates and measurements in the ultraviolet region are the basis of most of the commonly used methods to determine enzyme activities in clinical biochemistry. Typically, they continuously measure the absorbances of NAD+ or NADP+ at 340 nm. Figure shows the reactions used to monitor the activities of creatine kinase (CK) in clinical laboratories by measuring changes in the absorbance of NAD+ or NADP+. Clinical investigations using this enzyme can be used to detect muscle damage..
The approach to sepsis certainly needs to be based on organ involement. The mysteri of the role of the heart associated with myocardial dysfunction, becomes a growing scientific challenge
Myocardial dysfunction in sepsis jpcc jul aug 2018Lokesh Tiwari
Septic shock is a major cause of mortality in children. Myocardial dysfunction in severe sepsis and septic shock
is well recognized but its pathogenesis could be multifactorial. As a result of complex interplay of various factors,
hemodynamic changes observed in pediatric age group may be different from those observed in adult. Sepsis induced myocardial dysfunction (SIMD) is a known consequence of severe sepsis and septic shock. Although there is no
universally accepted defi nition of this entity, it can be best defi ned as reversible intrinsic myocardial systolic and diastolic dysfunction of both the left and right sides of the heart induced by sepsis. In this review we discuss the pathogenesis, pathophysiology of clinical manifestations, diagnosis and management of SIMD in children.
Key words: Sepsis induced myocardial dysfunction (SIMD), Severe Sepsis, Septic Shock
Entrepreneurship an idea is an opportunityKarim Soliman
1. Entrepreneurship an idea is an opportunity
2. Before we start
3. Anything that is worth memorizing is worth looking up. Seth Godin
4. Definition
5. Entrepreneur: No single definition
6. Walt Disney’s definition
“…. To do things and make things which will give pleasure to people in new and amazing ways. …. It is magic!
7. Forms of Entrepreneurship
Social Entrepreneurship
Business Entrepreneurship
8. Social Business Mix
NGO (non-profit) - NGO (for-profit) - Social Enterprise Social Business - Business Enterprise CSR - Profit Maximizing Business (PMB) Business Enterprise
9. Banker to the poor "Muhammad Yunus"
10. Sir Edmund Hillary was first to conquer Mt. Everest
11. Why are they entrepreneurs?
They had little or no resources at all but they survived and achieved what they wanted in life.
12. Business Entrepreneurship
13. The business cycle, according to Larry Farrel – Int’l expert on entrepreneurship
14. Entrepreneurship Is a PROCESS
15. Why Entrepreneurship?
16. Employees VS Entrepreneur "Money".
17. Special Power
18. Why NOT Entrepreneurship?
19. Risk
20. Peer Pressure
21. Work-Life Balance
22. An idea is An opportunity
23. Add Real Value
24. Solve a Problem
25. How to Start?
26. Creativity Vs Innovation
27. The Main 4 Types of Innovation
28. Product/Service "What we DO?"
29. Process Innovation " How we DO it?"
30. Business Model Innovation "How we make Money?"
31. Positioning Innovation "In our Marketing Mix"
32. One More Thing
33. So you want to be a billionaire - Put your name here
34. We are not perfect, Phones aren't perfect.
We want to make all of our users happy. "Steve Jobs"
35. Resources
Developing Innovative Ideas for New Companies: The First Step in Entrepreneurship
https://www.coursera.org/course/innovativeideas
Samsung Case Part 2: Innovation Process
https://www.youtube.com/watch?v=YRCip1KDR18
Types of innovation - Choosing where to innovate
http://www.innovation-management.org/types-of-innovation.html
Ten Types of Innovation:
The Discipline of Building Breakthroughs
https://www.doblin.com/tentypes/
35. Thank You
@KareemSamara
Founder & CEO of Social Business Kits
http://www.sbkits.com.my
An entrepreneurial culture consists of a group of individuals who have suppressed individual interests in an effort to achieve group success because group success will advance their individual interests. More Details available Inside.
This presentation is Made by Ruchi Sinha.
Mesurement of cretinine kinase from blood of a cardiac patientAtai Rabby
The development of sensitive spectrophotometer able to measure a wide range of wavelengths has allowed natural substrates and measurements in the ultraviolet region of the spectrum to be used in clinical tests. Assays using natural substrates and measurements in the ultraviolet region are the basis of most of the commonly used methods to determine enzyme activities in clinical biochemistry. Typically, they continuously measure the absorbances of NAD+ or NADP+ at 340 nm. Figure shows the reactions used to monitor the activities of creatine kinase (CK) in clinical laboratories by measuring changes in the absorbance of NAD+ or NADP+. Clinical investigations using this enzyme can be used to detect muscle damage..
The approach to sepsis certainly needs to be based on organ involement. The mysteri of the role of the heart associated with myocardial dysfunction, becomes a growing scientific challenge
Myocardial dysfunction in sepsis jpcc jul aug 2018Lokesh Tiwari
Septic shock is a major cause of mortality in children. Myocardial dysfunction in severe sepsis and septic shock
is well recognized but its pathogenesis could be multifactorial. As a result of complex interplay of various factors,
hemodynamic changes observed in pediatric age group may be different from those observed in adult. Sepsis induced myocardial dysfunction (SIMD) is a known consequence of severe sepsis and septic shock. Although there is no
universally accepted defi nition of this entity, it can be best defi ned as reversible intrinsic myocardial systolic and diastolic dysfunction of both the left and right sides of the heart induced by sepsis. In this review we discuss the pathogenesis, pathophysiology of clinical manifestations, diagnosis and management of SIMD in children.
Key words: Sepsis induced myocardial dysfunction (SIMD), Severe Sepsis, Septic Shock
Entrepreneurship an idea is an opportunityKarim Soliman
1. Entrepreneurship an idea is an opportunity
2. Before we start
3. Anything that is worth memorizing is worth looking up. Seth Godin
4. Definition
5. Entrepreneur: No single definition
6. Walt Disney’s definition
“…. To do things and make things which will give pleasure to people in new and amazing ways. …. It is magic!
7. Forms of Entrepreneurship
Social Entrepreneurship
Business Entrepreneurship
8. Social Business Mix
NGO (non-profit) - NGO (for-profit) - Social Enterprise Social Business - Business Enterprise CSR - Profit Maximizing Business (PMB) Business Enterprise
9. Banker to the poor "Muhammad Yunus"
10. Sir Edmund Hillary was first to conquer Mt. Everest
11. Why are they entrepreneurs?
They had little or no resources at all but they survived and achieved what they wanted in life.
12. Business Entrepreneurship
13. The business cycle, according to Larry Farrel – Int’l expert on entrepreneurship
14. Entrepreneurship Is a PROCESS
15. Why Entrepreneurship?
16. Employees VS Entrepreneur "Money".
17. Special Power
18. Why NOT Entrepreneurship?
19. Risk
20. Peer Pressure
21. Work-Life Balance
22. An idea is An opportunity
23. Add Real Value
24. Solve a Problem
25. How to Start?
26. Creativity Vs Innovation
27. The Main 4 Types of Innovation
28. Product/Service "What we DO?"
29. Process Innovation " How we DO it?"
30. Business Model Innovation "How we make Money?"
31. Positioning Innovation "In our Marketing Mix"
32. One More Thing
33. So you want to be a billionaire - Put your name here
34. We are not perfect, Phones aren't perfect.
We want to make all of our users happy. "Steve Jobs"
35. Resources
Developing Innovative Ideas for New Companies: The First Step in Entrepreneurship
https://www.coursera.org/course/innovativeideas
Samsung Case Part 2: Innovation Process
https://www.youtube.com/watch?v=YRCip1KDR18
Types of innovation - Choosing where to innovate
http://www.innovation-management.org/types-of-innovation.html
Ten Types of Innovation:
The Discipline of Building Breakthroughs
https://www.doblin.com/tentypes/
35. Thank You
@KareemSamara
Founder & CEO of Social Business Kits
http://www.sbkits.com.my
An entrepreneurial culture consists of a group of individuals who have suppressed individual interests in an effort to achieve group success because group success will advance their individual interests. More Details available Inside.
This presentation is Made by Ruchi Sinha.
Part One of Entrepreneurship Lecture Notes on Students Enterprise Club at www.studentsenterpriseclub.com.
This is a Study guide for intending Entrepreneurs.
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...Jorge Saguinsin
Introduction to basics of Entrepreneurship covers topics such as social entrepreneurship, business entrepreneurship and various masteries needed. The subject matter covers examples from the Philippines. This a compilation of various learnings from various references. These slides are lectures at Agsb entrepreneurship elective and have been uploaded for the access and convenience of present and past students of the said elective
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial Ricardo Mora MD
Tabaquismo como factor de riesgo endotelial y disfuncion endotelial; Dr. Ricardo Mora Moreno R2C; IMSS UMAE T1; León, Guanajuato, Mexico; 09 de Noviembre del 2017
In this ppt, I am going to discuss the role of ICD in the patient with Non-ischemic cardiomyopathy. I am going to discuss all the major trials done in the patient with non-ischemic cardiomyopathy.
FINAL.. beta blockers in cardiovascular disease.pptxdkapila2002
beta blockers have an ever increasing role in many cardiovascular disorders like heart failure,heart attacks,hypertension & SIHD. With new_generation beta-blockers,their efficacy has increased with fewer side effects.They now have a very important role in heart-failure & CAD,while lesser role in management of hypertension.Their present status in CV disorders according to latest guidelines is highlighted.The so called thierd generation betablockers have shown better efficacy with fewer side-effects though large scale randomized trials are lacking
European Society of Hypertension 2013 Hypertension guidelines presentation in...JAFAR ALSAID
Summary of the European Society of Hypertension 2013 Hypertension Guidelines presented during the Eighth Hypertension and Cardiovascular highlight session in Bahrain on Sept. 11th 2013.
1. Sidi A, Naik B, Muehlschlegel JD, Kirby DS, Lobato EB.
Ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs.
Br J Anaesth.2008 Apr;100(4):568-9. No abstract available.
PMID: 18344581 [PubMed - indexed for MEDLINE]
Sidi A, Naik B, Urdaneta F, Muehlschlegel JD, Kirby DS, Lobato EB
Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs, by sildenafil
analogue (UK343-664) or nitroglycerin. Ann Card Anaesth.2008 Jul-Dec;11(2):97-104.
PMID: 18603749
Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB.
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and
myocardial stunning in pigs. Acta AnaesthesiolScand.2008 Mar;52(3):397-405.
PMID: 18269389 [PubMed - indexed for MEDLINE]
Sidi A, Muehlschlegel JD, Kirby DS, Kirby RR, Lobato EB
Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs. J
Cardiothorac Vasc Anesth.2007 Jun;21(3):400-5. Epub 2007 Apr 5.
PMID: 17544894 [PubMed - indexed for MEDLINE]
Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone,
administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs. Ann Card
Anaesth.2007 Jan;10(1):34-41. Erratum in: Ann Card Anaesth.2008 Jan-Jun;11(1):69. Muehschlegel,Jochen D
[corrected to Muehlschlegel, Jochen D].
PMID: 17455406 [PubMed - indexed for MEDLINE
Muehlschlegal JD, Lobato EB, Kirby DS, Arnaoutakis G, Sidi A.
Inhaled amyl nitrite effectively reverses acute catastrophic thromboxane-mediated pulmonary hypertension in pigs.
Annalsof Cardiac Anaesthesia 2007 July; 10(2): 113-120
Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB. Treatment of ischaemic left ventricular dysfunction with
milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
British Journal of Anaesthesia 2006; 97: 799-807
Lobato EB, Beaver T, Muelschlegel J, Kirby DS, Klodell C, Sidi A.
Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination
during thromboxane-induced acute pulmonary hypertension. British Journal of Anaesthesia 2006 March; 96(3):
317-22
Botero M, Kirby D, Lobato EB, Staples ED, Gravenstein N
Measurement of cardiac output before and after cardiopulmonary bypass:Comparison among aortic transit-time
ultrasound,thermodilution, and noninvasive partial CO2 rebreathing. J Cardiothorac Vasc Anesth.2004
Oct;18(5):563-72. PMID: 15578466 [PubMed - indexed for MEDLINE]
Bonnell MR, Urdaneta F, Kirby DS, Valdez NR, Beaver TM, Lobato EB
Effects of sildenafil analogue UK 343-664 on a porcine model of acute pulmonary hypertension.Ann Thorac Surg.
2004 Jan;77(1):238-42.
PMID: 14726068 [PubMed - indexed for MEDLINE]
Urdaneta F, Kirby D, Lobato EB.
“Effects of ascorbic acid vs ketorolac on myocardial ischemia-reperfusion during propofol anesthesia,” abstracted.
Anesthesia Analgesia 94:S34, 2002.
Urdaneta F, Kirby D, Lobato EB.
2. “Myocardial stunning following transient coronary occlusion in pigs: comparison of propofol vs isoflurane,”
abstracted. Anesthesia Analgesia 94:S36, 2002.
Lobato EB, Botero M, Kirby DS, Browd CR, Sidi A, Kirby RR.
“Effects of beta-blockade and PDEIII inhibition on myocardial ischemia and function during temporary coronary
occlusion,” abstracted. Anesthesia Analgesia 92:S28, 2001.
Lobato EB, Sulek CA, Hollis S, Kirby D, Kirby RR.
“Hypertonic saline improves stunned myocardium following transient coronary occlusion in pigs,” abstracted.
Anesthesia Analgesia 92:S29, 2001.
Lobato EB ,Botero M, Kirby DS, Browd CR, Sidi A.
“Effect of milrinone on myocardial ischemia and stunning in the presence of calcium channel blockade in pigs,”
abstracted.Anesthesia Analgesia 92:SCA104, 2001.
Lobato EB ,Botero M, Kirby DS, Browd CR, Sidi A.
“Effects of combined PDEIII and PDEV inhibition on a porcine model of acute pulmonary hypertension,”
abstracted. Anesthesia Analgesia 92:SCA125, 2001.
Botero M, Briesacher K, Kirby D, Gravenstein N, Hess P, Lobato EB.
“Comparison of noninvasive cardiac output using a partial CO2 rebreathing systemwith direct aortic flow
measurements during cardiac surgery,” abstracted. Anesthesia Analgesia 90:S31, 2000.
Botero M, Bresacher K, Kirby D, Gravenstein N, Hess P, Lobato EB.
“Comparison of noninvasive determination of cardiac output (CO) using a partial CO2 rebreathing
systemwith thermodilution during cardiac surgery,” abstracted. Anesthesia Analgesia 90:S32, 2000.
Botero M, Hess P, Kirby D, Briesacher K, Gravenstein N.
“Cardiac output measurement during off pump coronary artery bypass grafting (OPCABG): comparison of four
methods,” abstracted. Anesthesia Analgesia 90:SCA44, 2000.
Botero M, Hess P, Kirby D, Briesacher K, Gravenstein N.
“Measurement of cardiac output during coronary artery bypass grafting (CABG): comparison of pulmonary
artery catheter, noninvasive CO2 rebreathing, and direct aortic flow,” abstracted. Anesthesia Analgesia 90:SCA87,
2000.
Botero M, Khansarinia S, Kirby D, Gravenstein N, Lobato EB.
“Noninvasive cardiac output using partial CO2 rebreathing vs direct aortic flow measurements during
off pump coronary artery bypass grafting,” abstracted. Anesthesiology 93:A323, 2000.
Botero M, Khansarinia S, Kirby D, Gravenstein N, Lobato EB.
“Measurement of cardiac output in the intensive care unit after coronary artery bypass grafting (CABG):
comparison of pulmonary artery catheterand noninvasive partial CO2 rebreathing,” abstracted. Anesthesiology
93:A590, 2000.
Botero M, Gravenstein N, Briesacher KS, Kirby D, Hess P, Lobato EB. “Thermodilution cardiac output monitoring
vs direct measurement of aortic flow during coronary artery bypass grafting,” abstracted. Critical Care Medicine
27:193, 1999.